A Double-Blind Randomized Multiple Center Clinical Trial on Observing the Effect of Fixed-Dose Glipizide/metformin on Type 2 Diabetes

郑旭琴,李红,沈备,王晓东,谷卫,匡洪宇,李强,刘超

DOI: https://doi.org/10.3969/j.issn.1672-2353.2008.12.002

2008-01-01

Abstract:Objective To evaluate the effect and safety of fixed-dose glipizide/metformin tablets on type 2 diabetes.Methods This is a double blind randomized 12-week clinical observation on multiple centers comparing the blood glucose lowering effect and safety between fixed-dose glipizide/metformin tablets and glipizide co-administered with metformin.Results The cohort consisted of 113 patients who received glipizide/metformin tablets and 111 taking glipizide co-administered with metformin on five centers.The patients in both groups got a significant reduction in fasting blood glucose(FBG),2 hours postprandial blood glucose(PBG 2 h) and glycosylated hemoglobin(HbA1c)values after 12-week therapy.There was a significant decrease of fasting insulin level,whereas 2 hours postprandial insulin level was increased.No statistical difference between two groups was found.The rates of side effect in two groups showed no statistical difference.Conclusions Fixed-dose glipizide/metformin is convenient,effective and safe blood glucose lowering drug for diabetic patients.